Venture capitalist Mark Carnegie was alerted years ago by a science adviser to a Californian developer of a wireless heart pacemaker that could save the lives of some patients, but he baulked at the terms.
Every month the adviser would call Mr Carnegie and say, “I have got another CRT patient who is going to die because he is not responding to treatment. When are you going to do something about this?” Mr Carnegie told The Australian Financial Review.